🔹 ARB is currently in a consolidation phase, and once Ethereum starts to rise, it is expected to achieve its targets strongly. Suitable for the medium term.

🔹 SXT has started to improve, but stronger opportunities have appeared in the market currently. Those who are in should monitor, and those who have not entered yet should look at alternatives.

🔹 BIO achieved two targets (7%) and returned slightly above the entry point. It may retest the target areas again, but if you did not enter from the beginning, I do not recommend entering now.